Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06836440

Impact of Glasses for Vision Problems on Cognitive Function in Rural Older Adults

The aim of this project is to explore whether vision correction can effectively slow cognitive decline in older adults.

The primary question it seeks to answer is: Can providing free near and/or distance vision correction glasses to older adults with refractive errors or uncorrected vision, who have normal baseline cognition and hearing, reduce the rate of cognitive decline over 36 months in a cost-effective manner? Researchers will compare the rate of cognitive decline over 36 months between older adults who receive refractive correction and those who do not.

Recruiting

Interested in participating?

Request Info

Key information

Age range

60 year–79 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Community health service centers

Ya'an, Sichuan, 610065, China

Location status: Recruiting

About this study

Exploratory subgroup analyses will be conducted to assess whether the intervention effect on cognitive decline differs according to baseline vision correction needs (near vision correction, distance vision correction, or both) and baseline cognitive function. These analyses will be interpreted cautiously due to their exploratory nature.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Older adults who meet all of the following criteria will be eligible to participate in this study:
  • Registered as a rural resident (holding rural household registration);
  • Age from 60 to 79 years at the time of enumeration;
  • Resident in the household for > = 3 months and planning to reside in the local area for the trial duration;
  • Distance vision impairment (VI, presenting visual acuity [VA] < 6/12 in the better-seeing eye and improving to ≥ 6/7.5 or better in either eye with spectacle correction) and/or near VI (presenting near VA < 6/12 at 40 cm when measured binocularly and improving to ≥ 6/7.5 or better in either eye with near correction);
  • Independent mobility with or without the support of a walking stick;
  • Chinese version of the Mini-Mental State Examination (C-MMSE) score above the following cut-offs (out of 30): >17 for illiterate participants, >20 for those with primary school education, >22 for those with junior high school education, and >23 for those with high school education or above.
  • Willingness to participate, to be randomized to either study group, and to adhere to the protocol

Exclusion criteria

  • Presence of glaucoma or visually significant cataract, or a history of surgical treatment for these or other major ocular conditions;
  • Consistent use of prescription spectacles and/or hearing aids;
  • Serious medical illness likely to result in loss to follow-up. Those less severely affected by conditions such as hypertension and/or diabetes will be eligible;
  • Failure on the whispered voice hearing screening test in the better ear (unable to repeat > = 3 out of 6 words whispered from behind the participant at a distance of 50 cm);

Treatment and study plan

Free Prescription Glasses

Device

Participants can choose from a variety of frames, and the research team will customize the glasses according to their pupillary distance and prescription. Once the glasses are ready, they will be provided to the participants following standard usage instructions. In case of loss or damage, participants should report it to the project team and will be provided with replacement glasses as needed. Each year, participants in the intervention group will undergo an eye exam to assess changes in vision, and their glasses prescription will be updated if necessary.

Primary outcomes

  1. Change in global cognitive function

    Time frame: Baseline to 12, 24, and 36 months

    The primary outcome will be the change in global cognitive function from baseline to the 36-month follow-up, assessed by the total score of the Chinese version of the Montreal Cognitive Assessment Basic (MoCA-BC) . The MoCA-BC was selected because it minimizes reading and writing requirements and has been widely used in China, allowing for reliable cognitive assessment among individuals who are illiterate or have limited formal education.

Secondary outcomes

  1. Change in domain-specific cognitive function

    Time frame: Baseline to 12, 24, and 36 months

    Secondary outcomes include domain-specific cognitive performance derived from a composite cognitive battery based on the China Health and Retirement Longitudinal Study (CHARLS) cognitive assessments. The CHARLS-based cognitive battery comprises a set of task-based cognitive assessments, such as measures of orientation, episodic memory, verbal fluency, and executive function. These tasks rely primarily on oral responses, making them particularly suitable for participants with uncorrected refractive errors, for whom visually demanding tasks may be challenging.

  2. Change in falls risk

    Time frame: Baseline to 12, 24, and 36 months

    Falls risk will be assessed using the prespecified falls-risk assessment included in the study protocol.

  3. Change in vision-related quality of life

    Time frame: Baseline to 12, 24, and 36 months

    Vision-related quality of life will be assessed using the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25).

  4. Change in health-related quality of life

    Time frame: Baseline to 12, 24, and 36 months

    Health-related quality of life will be assessed using the EQ-5D-5L.

  5. Change in depressive symptoms

    Time frame: Baseline to 12, 24, and 36 months

    Depressive symptoms will be assessed using the 9-item Patient Health Questionnaire (PHQ-9).

  6. Change in physical activity

    Time frame: Baseline to 12, 24, and 36 months

    Physical activity will be assessed using the short form of the International Physical Activity Questionnaire (IPAQ-SF)

  7. Change in social network

    Time frame: Baseline to 12, 24, and 36 months

    Social network will be assessed using the Lubben Social Network Scale-6 (LSNS-6)

  8. Cost-effectiveness of the intervention

    Time frame: From baseline through 36 months

    Cost-effectiveness will be expressed as the incremental cost per quality-adjusted life year (QALY) gained in the intervention group compared with the control group. Costs will include healthcare service utilization and associated costs assessed using CSRI-adapted items and productivity-related information collected using the WPAI. QALYs will be derived from EQ-5D-5L utility scores.

Interested in participating?

Recruiting

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

Yuju Wu

Other

Registry information

Official study title

The Impact of Spectacle Intervention for Refractive Error and Presbyopia on Cognitive Function in Rural Older Adults

Acronym: CLEVER

Important dates

Study start
2025
Primary completion
2028
Study completion
2030
First posted
Feb 20, 2025
Registry last updated
Sep 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.